From rxpgnews.com
"The Size and Burden of Mental Disorders in Europe" - EU Benchmark Study Published
By Elsevier
Oct 6, 2005, 21:57
On the eve of World Mental Health Day, Elsevier announced the publication of "The Size and Burden of Mental Disorders in Europe", an unprecedented EU-wide task force report commissioned by the European College of Neuropsychopharmacology (ECNP) and the European Brain Council (EBC). The report covering critical findings on the state of mental health in Europe will appear in a special issue of European Neuropsychopharmacology, one of Elsevier's premier journals and the official publication of the ECNP. In addition, the report will receive in depth treatment at the 18th ECNP Congress in Amsterdam, The Netherlands from October 22-26 2005.
"The Size and Burden of Mental Disorders in Europe", includes the most salient findings from a total of 150,000 subjects and 27 studies conducted across Europe. Core findings reveal Europe's enormous burden in terms of disabilities associated with mental disorders: during any given year, 93 million people, or 27% of the EU population, experience at least one mental disorder such as anxiety, depression, schizophrenia, substance dependence, social phobia or panic disorder. Scholars predict that as new benchmark data, European Neuropsychopharmacology's special report will have profound consequences for future research, health care and policy issues. In addition, the report identifies critical gaps in the knowledge of specific mental disorders and the reasons for the current under-treatment of mental disorders within Europe.
The principal investigator of the ECNP special report task force, Hans-Ulrich Wittchen, Professor of Clinical Psychology at the Technical University Dresden, Germany, noted, "We believe that the newly established interdisciplinary network which emerged from the "Size and Burden" is an important starting point for future coordinated and continuous high-quality mental health research, as well as better funding for research, training and education programmes."
Nello Spiteri, Publisher of European Neuropsychopharmacology at Elsevier remarked, "World Mental Health Day is always an important moment to pause and reflect on the new research being done-and the advances achieved-in the field of mental health. We are very pleased that this special issue of European Neuropsychopharmacology will contribute to increasingly informed European research and policy choices in the future."
All rights reserved by www.rxpgnews.com